For children living with sickle cell disease, the most consequential damage is often the kind no one sees — the quiet erosion of learning, memory, and decision-making that accumulates long before a crisis announces itself. Children's Hospital Colorado, drawing on years of integrated lifelong care, has helped author the first national standards for identifying and managing these cognitive and developmental challenges, offering a framework that could finally make a child's zip code irrelevant to the quality of their neurological care.
Children's Colorado leads development of national sickle cell disease neurodevelopmental care standards
Sickle cell disease patients experience developmental delays and cognitive challenges affecting learning, decision-making, and daily functioning throughout their lives without proper early identification and intervention.
Without early identification, you lose the chance to help patients succeed
Mark
Why does a hospital in Colorado get to write national standards? What makes them the authority here?
Mimi
They didn't write them alone—it was a workgroup of experts across the country. But Children's Colorado had something most hospitals don't: a working model. They've been doing integrated neurodevelopmental care for sickle cell patients since 2019. They had years of data showing it works.
Luke
So the standards are based on one hospital's experience, even if it's a good one. How many other programs are doing this level of integrated care?
Mimi
The source says Children's Colorado is "one of the few programs offering this level of integration." So it's rare. That's partly why the standards matter—they're trying to spread what works.
Mark
What exactly changed with these new standards? What was wrong with the old way?
Mimi
The old approach was reactive. You'd test a patient if something went wrong. The new model is proactive—screening at regular developmental stages starting in infancy, whether or not there's a crisis.
Luke
That sounds good in theory. But do we know it actually improves outcomes? The source talks about what the program does, but does it say whether kids actually do better?
Mimi
It doesn't give outcome data, no. It says the model "helped shape" the standards and that the hospital serves as a "regional hub," but there's no before-and-after comparison.
Mark
So we're taking it on faith that this works better than the old way.
Luke
Not entirely. The logic is sound—catching problems early gives you time to intervene. But you're right that the source doesn't prove it reduces disparities or improves lives. It shows a model exists and got codified into guidelines.
Mimi
Fair. What we know for certain is that sickle cell patients have cognitive and developmental challenges that often go undetected, and that care varies by geography. The standards are meant to fix that. Whether they actually do is a question for follow-up reporting.
Mark
And the access problem—the source mentions barriers to care. What are those barriers?
Luke
The source doesn't say. It mentions "reducing barriers" as a goal but doesn't name what they are. Cost? Geography? Lack of trained neuropsychologists? We don't know.
Il Polso
- Sickle cell disease quietly undermines how patients think, learn, and function throughout life — even in those who never experience a stroke — yet most care systems only respond after something visibly breaks.
- Without early screening, children miss critical windows for school accommodations, therapies, and interventions that could reshape their long-term outcomes, and the gap between what's possible and what's delivered varies dramatically by geography.
- The new national standards replace reactive, crisis-driven testing with a tiered model — routine surveillance from infancy, screening at key developmental milestones, and full neuropsychological evaluation when warranted — built on what Children's Colorado learned over years of doing the work.
- The standards are published, but the harder task remains: persuading hospitals nationwide to adopt them, training clinicians in the tiered approach, and dismantling the financial and logistical barriers that still keep many patients from reaching neuropsychological care at all.
For children living with sickle cell disease, the most consequential damage is often the kind no one sees — the quiet erosion of learning, memory, and decision-making that accumulates long before a crisis announces itself. Children's Hospital Colorado, drawing on years of integrated lifelong care, has helped author the first national standards for identifying and managing these cognitive and developmental challenges, offering a framework that could finally make a child's zip code irrelevant to the quality of their neurological care.
Children's Hospital Colorado has spent years doing something rare — following sickle cell patients from infancy through adulthood, watching not only for blood crises but for the subtler damage the disease does to how children learn and think. That model is now becoming a national blueprint.
Working with the National Alliance of Sickle Cell Centers, the hospital helped write the first comprehensive national standards for identifying and managing the developmental and cognitive challenges that accompany sickle cell disease. The stakes are high: care quality currently varies so widely by location that one child might be screened for learning problems at age three while another is never tested until something goes visibly wrong.
Sickle cell disease carries an invisible cognitive toll. Even patients who never have a stroke often struggle with developmental delays that affect reading, decision-making, and self-management throughout their lives. Without early identification, care teams miss the window to connect patients with accommodations and therapies that could change their trajectory. As pediatric neuropsychologist Arianna Martin noted, catching these problems early is essential to helping patients succeed and live well long-term.
The new standards shift care from reactive to systematic — routine surveillance beginning in infancy, regular screening at key developmental moments, and full neuropsychological evaluation when the clinical picture calls for it. They also emphasize family education and coordinated multidisciplinary care built into sickle cell specialty programs rather than fragmented across separate clinics.
Children's Colorado established its neurodevelopmental monitoring program in 2019, embedding it within its hematology program and serving more than 200 sickle cell patients a year across the full lifespan. Program director Christopher McKinney describes it as continuity — knowing a patient's whole story, preparing teenagers to manage their own care, maintaining relationships over decades. That accumulated experience shaped the national standards directly.
The guidance is published. But the real work lies ahead: getting hospitals to adopt the tiered model, training clinicians, and reducing the financial and logistical barriers that still prevent many patients from accessing neuropsychological services — because a good standard means nothing if patients cannot reach the care it describes.
Children's Hospital Colorado has spent years building something most hospitals don't have: a program that follows sickle cell patients from infancy through adulthood, watching not just for blood crises but for the quieter damage the disease does to how children learn and think. Now that model is becoming the blueprint for the nation.
The hospital worked with the National Alliance of Sickle Cell Centers to write the first comprehensive national standards for identifying and managing the developmental and cognitive problems that come with sickle cell disease. The work matters because care for these patients varies wildly depending on where they live. A child in one state might get screened for learning problems at age three; another might never be tested until something breaks. The new guidance aims to flatten that geography, to make sure that a sickle cell patient in any clinic gets the same thoughtful, proactive attention to their brain and development.
Sickle cell disease carries an invisible tax on cognition. Even patients who never have a stroke—the dramatic, feared complication—often struggle with developmental delays and cognitive challenges that ripple through their lives. These aren't small things. They affect how a child learns to read, how an adult makes decisions, how someone manages their own health. Without early identification, care teams miss the window to connect patients with school accommodations, therapies, and resources that could change the trajectory. Arianna Martin, a pediatric neuropsychologist at Children's Colorado, put it plainly: without catching these problems early, you lose the chance to help patients succeed long-term and live well.
The new standards move away from the old reactive model—waiting for a crisis to test—toward something more systematic. They describe a tiered approach: routine surveillance starting in infancy, regular screening at key developmental moments as children grow, and full neuropsychological evaluation when the picture warrants it. The guidance is clearer about which risk factors should trigger comprehensive assessment. It emphasizes educating patients and families so they can spot concerns themselves. And it pushes for coordinated care, with developmental monitoring built into sickle cell specialty programs rather than scattered across separate clinics.
Children's Colorado built this model first. The hospital established its neurodevelopmental monitoring program in 2019, weaving it into the hematology program within the Center for Cancer and Blood Disorders. The setup is rare: a multidisciplinary team that sees more than 200 sickle cell patients a year from infancy into adulthood, offering not just medical care but transition planning for teenagers, nutrition services, and access to specialized cognitive assessments. Christopher McKinney, who directs the pediatric sickle cell program, describes it as continuity—the ability to know a patient's whole story, to prepare them to manage their own care as they age, to maintain relationships over decades.
That continuity shaped the national standards. The new guidance reflects what Children's Colorado learned by doing the work year after year: that early identification matters, that ongoing assessment catches problems that would otherwise hide, that coordinated lifelong care produces better outcomes. Alyssa Schlenz, the lead author of the standards and chair of the workgroup that wrote them, said the effort was about more than establishing rules—it was about elevating the quality of care itself, making sure every aspect of the disease gets fully and thoughtfully addressed no matter where a patient receives treatment.
The standards are published now. But the real work is ahead: getting hospitals across the country to adopt them, training clinicians to use the tiered model, and reducing the barriers—financial, logistical, educational—that keep many patients from accessing neuropsychological services at all. Children's Colorado and the National Alliance continue to push on that front, knowing that a good guideline means nothing if patients can't reach the care it describes.
Citazioni salienti
Without early identification, care teams risk the ability to connect patients with the right supports—from school accommodations to therapies and community resources—so they can succeed long-term and have the best possible quality of life.— Arianna Martin, pediatric neuropsychologist at Children's Colorado
What makes our program unique is the continuity and depth of care we're able to provide from infancy through adulthood. We not only support patients medically but also prepare them to successfully transition out of the hospital and manage their care independently.— Christopher McKinney, director of the Pediatric Sickle Cell and Hemoglobinopathy Program at Children's Colorado
Vuoi la storia completa?
Leggi l'originale su News-Medical.net ↗
Health & Medicine